Advances in the structural understanding of Vif proteins

被引:41
作者
Barraud, Pierre
Paillart, Jean-Christophe [2 ]
Marquet, Roland [2 ]
Tisne, Carine [1 ]
机构
[1] Univ Paris 05, Lab Cristallog, CNRS, UMR 8015, F-75006 Paris, France
[2] Univ Strasbourg, Architecture & React ARN, CNRS, IBMC, Strasbourg, France
关键词
Vif protein; APOBEC3G; Cullin5; elongin; reverse transcription; RNA;
D O I
10.2174/157016208783885056
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The multidomain HIV-1 Vif protein recruits several cellular partners to achieve neutralization of the antiviral activity of APOBEC3 proteins. Vif neutralizes APOBEC3G and APOBEC3F predominantly by forming an E3 ubiquitin ligase with Cullin5, ElonginB and ElonginC that targets these proteins for degradation by the ubiquitin-proteasome pathway. Vif associates with the Cullin5-ElonginB-ElonginC complex by binding directly to ElonginC via its SOCS-box motif and to Cullin5 via hydrophobic residues within a zinc-binding region formed by a conserved HCCH motif. The HIV-1 Vif-Cullin5-ElonginBC complex is then able to ubiquitinate the APOBEC3G factor bound to Vif by its N-terminal domain. In this review, we summarize the current knowledge about the structural determinants of Vif that allow it to interact with cellular and viral partners.
引用
收藏
页码:91 / 99
页数:9
相关论文
共 88 条
[1]   Mass spectrometry analysisof HIVA Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity [J].
Auclair, Jared R. ;
Green, Karin M. ;
Shandilya, Shivender ;
Evans, James E. ;
Somasundaran, Mohan ;
Schiffer, Celia A. .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 69 (02) :270-284
[2]   Paradigm development: Comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (vif) [J].
Balaji, Seetharaaman ;
Kalpana, Rangaswamy ;
Shapshak, Paul .
BIOINFORMATION, 2006, 1 (08) :290-309
[3]   Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors:: co-encapsidation and interference with viral protease-mediated Gag processing [J].
Bardy, M ;
Gay, B ;
Pébernard, S ;
Chazal, N ;
Courcoul, M ;
Vigne, R ;
Decroly, E ;
Boulanger, P .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :2719-2733
[4]   New insights into the formation of HIV-1 reverse transcription initiation complex [J].
Barraud, Pierre ;
Gaudin, Cyril ;
Dardel, Frederic ;
Tisne, Carine .
BIOCHIMIE, 2007, 89 (10) :1204-1210
[5]   RNA and DNA binding properties of HIV-1 vif protein - A fluorescence study [J].
Bernacchi, Serena ;
Henriet, Simon ;
Dumas, Philippe ;
Paillart, Jean-Christophe ;
Marquet, Roland .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (36) :26361-26368
[6]   A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor [J].
Bogerd, HP ;
Doehle, BP ;
Wiegand, HL ;
Cullen, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (11) :3770-3774
[7]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY [J].
BORMAN, AM ;
QUILLENT, C ;
CHARNEAU, P ;
DAUGUET, C ;
CLAVEL, F .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2058-2067
[8]   Characterization of human immunodeficiency virus type 1 Vif particle incorporation [J].
Camaur, D ;
Trono, D .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6106-6111
[9]   The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G [J].
Conticello, SG ;
Harris, RS ;
Neuberger, MS .
CURRENT BIOLOGY, 2003, 13 (22) :2009-2013
[10]   PERIPHERAL-BLOOD MONONUCLEAR-CELLS PRODUCE NORMAL AMOUNTS OF DEFECTIVE VIF(-) HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES WHICH ARE RESTRICTED FOR THE PRERETROTRANSCRIPTION STEPS [J].
COURCOUL, M ;
PATIENCE, C ;
REY, F ;
BLANC, D ;
HARMACHE, A ;
SIRE, J ;
VIGNE, R ;
SPIRE, B .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2068-2074